News & Updates
Filter by Specialty:
Glycaemic control not a risk factor for cerebral small vessel disease in T1D
Among patients with type 1 diabetes (T1D), medium- and long-term blood glucose control and long-term glycaemic variability do not exert any influence on the risk of developing cerebral small vessel disease, a study has found.
Glycaemic control not a risk factor for cerebral small vessel disease in T1D
16 Mar 2022
Early menopause tied to increased dementia risk
Individuals who experience menopause before age 50 years may be at an elevated risk of developing dementia, according to results of a UK study presented at the EPI Lifestyle Scientific Sessions 2022.
Early menopause tied to increased dementia risk
15 Mar 2022
Empagliflozin lowers blood pressure in T2D
Among hypertensives with type 2 diabetes (T2D), treatment with the sodium-glucose cotransporter 2 inhibitor empagliflozin produces clinically meaningful reductions in blood pressure, reports a recent study.
Empagliflozin lowers blood pressure in T2D
12 Mar 2022
Hyperbaric oxygen therapy promising for T2DM complications
Hyperbaric oxygen therapy (HBOT) may be an effective treatment approach for several complications of type 2 diabetes mellitus (T2DM), such as nephropathy and retinopathy, a recent study has found.
